Clinical Trial Update: Study of LL-BMT1 in Patients With Elevated Intraocular Pressure [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of LL-BMT1 in patients with elevated intraocular pressure has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• LL-BMT1

Snippet

Sponsor: MediPrint Ophthalmics, Inc. | Conditions: Primary Open Angle Glaucoma, Ocular Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2022-05-10